DLB250117P80000
- 2.80
- 0.000.00%
Dolby Laboratories Newsroom
Rosenblatt Securities Maintains Dolby Laboratories(DLB.US) With Buy Rating, Raises Target Price to $100
Barrington Maintains Dolby Laboratories(DLB.US) With Buy Rating, Maintains Target Price $100
Dolby Laboratories Is Maintained at Outperform by Barrington Research
Bullish Outlook on Dolby Laboratories: Strategic Acquisitions and Technological Advancements Drive Buy Rating
Rosenblatt Maintains Buy on Dolby Laboratories, Raises Price Target to $100
Dolby Laboratories Analyst Ratings
Dolby Laboratories Analyst Ratings
Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $100 Price Target
Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $100 Price Target
Dolby Laboratories: A Buy Rating With Growth and Stability Insights
Dolby Laboratories Analyst Ratings
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Barrington Upgrades Dolby Laboratories to Outperform From Market Perform, Price Target Is $100
Dolby Laboratories Analyst Ratings
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Rosenblatt: Maintains Dolby Laboratories (DLB.US) rating, adjusted from buy to buy rating, and adjusted target price from $98.00 to $98.00.
Dolby Laboratories Analyst Ratings
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Dolby Laboratories Analyst Ratings
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target